Interaction of miltefosine with intercellular membranes of stratum corneum and biomimetic lipid vesicles


Autoria(s): Alonso, Lais; Mendanha, Sebastiao Antonio; Marquezin, Cassia Alessandra; Barioni, Marina Berardi; Ito, Amando Siuiti; Ulises Acuna, A.; Alonso, Antonio
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

21/10/2013

21/10/2013

2012

Resumo

Miltefosine (MT) is an alkylphospholipid approved for breast cancer metastasis and visceral leishmaniasis treatments, although the respective action mechanisms at the molecular level remain poorly understood. In this work, the interaction of miltefosine with the lipid component of stratum corneum (SC), the uppermost skin layer, was studied by electron paramagnetic resonance (EPR) spectroscopy of several fatty acid spin-labels. In addition, the effect of miltefosine on (i) spherical lipid vesicles of 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) and (ii) lipids extracted from SC was also investigated, by EPR and time-resolved polarized fluorescence methods. In SC of neonatal Wistar rats, 4% (w/w) miltefosine give rise to a large increase of the fluidity of the intercellular membranes, in the temperature range from 6 to about 50 degrees C. This effect becomes negligible at temperatures higher that ca. 60 degrees C. In large unilamelar vesicles of DPPC no significant changes could be observed with a miltefosine concentration 25% molar, in close analogy with the behavior of biomimetic vesicles prepared with bovine brain ceramide, behenic acid and cholesterol. In these last samples, a 25 mol% molar concentration of miltefosine produced only a modest decrease in the bilayer fluidity. Although miltefosine is not a feasible skin permeation enhancer due to its toxicity, the information provided in this work could be of utility in the development of a MT topical treatment of cutaneous leishmaniasis. Published by Elsevier B.V.

CNPq

CNPq

CAPES

CAPES

FUNAPE

FUNAPE

FAPESP

FAPESP

MCINNSpain

MCINN-Spain [CTQ2010/16457]

Identificador

INTERNATIONAL JOURNAL OF PHARMACEUTICS, AMSTERDAM, v. 434, n. 41306, supl. 1, Part 1, pp. 391-398, SEP 15, 2012

0378-5173

http://www.producao.usp.br/handle/BDPI/35348

10.1016/j.ijpharm.2012.06.006

http://dx.doi.org/10.1016/j.ijpharm.2012.06.006

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE BV

AMSTERDAM

Relação

INTERNATIONAL JOURNAL OF PHARMACEUTICS

Direitos

closedAccess

Copyright ELSEVIER SCIENCE BV

Palavras-Chave #EPR #FLUORESCENCE #SPIN LABEL #MILTEFOSINE #STRATUM CORNEUM #PHOSPHOLIPID BILAYER #SPIN-LABEL #VISCERAL LEISHMANIASIS #PHOSPHOLIPID ANALOGS #PROTEIN DYNAMICS #ORAL TREATMENT #EPR-SPECTRA #HEXADECYLPHOSPHOCHOLINE #SPECTROSCOPY #CHEMOTHERAPY #MECHANISMS #PHARMACOLOGY & PHARMACY
Tipo

article

original article

publishedVersion